[Clinical efficacy of reamberine in therapy for influenza].

Aim: To evaluate the tolerance and therapeutic effectiveness of 1.5% reamberine (RB) solution infusions in complex therapy for pneumonia-complicated pneumonia and acute respiratory diseases (ARD).

Subjects And Methods: 133 patients aged 18 to 60 years with pneumonia-complicated influenza and ARD were examined.